Skip to main content
Equibles

Caption Management, LLC

Position in RZLT — Rezolute, Inc.

CIK 1706766 OKLAHOMA CITY, OK
Back to RZLT Full portfolio

Position in RZLT

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$0
-$1,416 QoQ
Shares Held
0
-100.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2024
6 quarters on record

Common Shares in RZLT Over Time

Shares Held

Position Value (USD)

Derivatives in RZLT

reported options exposure · as of Jun 30, 2026
CallValue
$520,000
CallShares
100,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Caption Management, LLC holds $249,760,911 across 78 Biotechnology names.

# Ticker Company Shares Value (USD) Open
1 CGON
CG Oncology, Inc.
 484,461 $34,420,954
2 INSM
INSMED Inc
 236,000 $25,162,320
3 ERAS
Erasca, Inc.
 1,041,225 $19,075,242
4 CELC
Celcuity Inc.
 170,000 $17,785,400
5 DSGN
Design Therapeutics, Inc.
 1,118,098 $16,178,878
6 MLYS
Mineralys Therapeutics, Inc.
 413,087 $11,145,087
7 REPL
Replimune Group, Inc.
 783,873 $8,677,474
8 TARS
Tarsus Pharmaceuticals, Inc.
 120,700 $7,596,858

All Filings in RZLT

Export CSV
11 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $520,000 100,000
2025-12-31 $810,424 343,400
2025-12-31 $1,416 600
2025-09-30 $815,929 86,801
2025-09-30 $4,091,820 435,300
2025-06-30 $446,000 100,000
2025-06-30 $1,271,100 285,000
2025-03-31 $536,500 185,000
2025-03-31 $144,715 49,902
2024-12-31 $231,804 47,307
2024-12-31 $906,500 185,000